NextTrip Inc News - NTRP

Professional-Grade Tools, for Individual Investors.

FeaturedCannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer

FeaturedBioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL

Proxy Statement - Merger or Acquistion (definitive) (defm14a)

FALSEXCEL ENERGY INC0000072903MNNORTHERN STATES POWER CO0001123852MN00000729032020-11-022020-11-020000072903xel:NSPMinnesotaMember2020-11-02202...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Neurotrope Announces First Patient Dosed in Long-Term Clinical Trial of Bryostatin in Alzheimer's Disease

Neurotrope Announces First Patient Dosed in Long-Term Clinical Trial of Bryostatin in Alzheimer's Disease - Study Being Conducted in...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM...

Current Report Filing (8-k)

0001513856 false 0001513856 2020-09-30 2020-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares ...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM...

Current Report Filing (8-k)

0001513856 false 0001513856 2020-09-28 2020-09-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares ...

Neurotrope Shareholders to Own 49 Percent of Petros Under Revised Merger Agreement with Metuchen

Neurotrope Shareholders to Own 49 Percent of Petros Under Revised Merger Agreement with Metuchen Neurotrope Shareholders, Currently Representing...

Quarterly Report (10-q)

P3Y236740895000.001013068023false2020Q2--12-310001513856P10DP60D0001513856us-gaap:RetainedEarningsMember...

Wayne R 4 weeks ago

Tanking, what a surprise.

👍️0

Wayne R 2 months ago

Toxic financing agreement.

Run away

	Real-time Prices	Level 2
Dow Jones Indices
OTCBB
New York Stock Exchange
NASDAQ
American Stock Exchange
OTCMarkets
Precious Metal

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

NextTrip Inc (NTRP)

Professional-Grade Tools, for Individual Investors.

NTRP News

FeaturedCannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer

FeaturedBioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL

Proxy Statement - Merger or Acquistion (definitive) (defm14a)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Neurotrope Announces First Patient Dosed in Long-Term Clinical Trial of Bryostatin in Alzheimer's Disease

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Neurotrope Shareholders to Own 49 Percent of Petros Under Revised Merger Agreement with Metuchen

Quarterly Report (10-q)

NTRP Discussion

Your Recent History

BLACK FRIDAY

Save up to 65%* for Small Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

NextTrip Inc (NTRP) News

NextTrip Inc (NTRP)

Professional-Grade Tools, for Individual Investors.

NTRP News

FeaturedCannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer

FeaturedBioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL

Proxy Statement - Merger or Acquistion (definitive) (defm14a)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Neurotrope Announces First Patient Dosed in Long-Term Clinical Trial of Bryostatin in Alzheimer's Disease

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Neurotrope Shareholders to Own 49 Percent of Petros Under Revised Merger Agreement with Metuchen

Quarterly Report (10-q)

NTRP Discussion

Your Recent History